openPR Logo
Press release

Market Trend Analysis: The Impact of Recent Advances on the Veterinary Biomarkers Market

04-08-2026 10:09 AM CET | Health & Medicine

Press release from: The Business Research Company

Veterinary Biomarkers Market

Veterinary Biomarkers Market

The veterinary biomarkers sector is showing strong promise as it moves toward the end of the decade, driven by technological progress and increasing demand for advanced animal health solutions. This market is set to witness significant transformations as innovations and investments continue to shape its future landscape. Below, we explore the expected market growth, key players, prevailing trends, and the segmentation that defines this evolving industry.

Projected Expansion and Size of the Veterinary Biomarkers Market by 2030
The veterinary biomarkers market is poised for rapid expansion, anticipated to reach a valuation of $1.61 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 12.0%. Several factors contribute to this upward trajectory, including breakthroughs in biomarker discovery, greater financial input into veterinary diagnostics, and an increased focus on animal health monitoring. The market is also benefiting from the expansion of companion and production animal sectors, along with the widespread adoption of automated biomarker readers and digital platforms. Significant trends shaping the market include the broadening of diagnostic biomarker applications, enhanced use of predictive and prognostic biomarkers, rising popularity of ELISA, PCR, and rapid testing kits, incorporation of sophisticated biomarker readers and analytical devices, and heightened attention to both companion and production animal health.

Download a free sample of the veterinary biomarkers market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20680&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Notable Companies Emerging in the Veterinary Biomarkers Landscape
A variety of influential companies are actively shaping the veterinary biomarkers market. Some of the prominent names include Thermo Fisher Scientific Inc., Zoetis Inc., IDEXX Laboratories Inc., Antech Diagnostics Inc., Neogen Corporation, Heska Corporation, Olink Proteomics, SomaLogic, Life Diagnostics Inc., INDICAL BIOSCIENCE GmbH., Mercodia AB, Bionote USA Inc., Acuvet Biotech, Alertix Veterinary Diagnostics AB., MI:RNA Diagnostics Ltd., Veterinary Biomarkers Inc., Vetmaya Healare Private Limited, VolitionRx, BioVet Diagnostics, Randox Laboratories Ltd., Bio-Rad Laboratories Inc., QIAGEN N.V., FidoCure, Scil Animal Care Company GmbH, Shenzhen Mindray Animal Medical Technology Co. Ltd., Esaote SPA, Innovative Diagnostics SAS, and Ayoxxa Biosystems.

Recent Strategic Acquisition Strengthening Zoetis Inc.'s Position
In November 2025, Zoetis Inc., a US-based leader in animal health products and diagnostic solutions, acquired Veterinary Pathology Group (VPG) for an undisclosed amount. This acquisition aimed to broaden Zoetis's veterinary diagnostics portfolio, enhancing its capacity to offer advanced biomarker and pathology testing services to veterinarians in the UK and Ireland, while reinforcing its global presence in diagnostics. VPG, based in the UK and Ireland, provides comprehensive laboratory diagnostic services that support biomarker-based testing for disease detection and monitoring in animal health, making it a valuable addition to Zoetis's offerings.

View the full veterinary biomarkers market report:
https://www.thebusinessresearchcompany.com/report/veterinary-biomarkers-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Strategic Partnerships and Innovations Driving the Veterinary Biomarkers Market
Companies within the veterinary biomarkers industry are increasingly focusing on strategic collaborations to maintain a competitive advantage. These partnerships often involve cooperation among corporations, research institutions, and veterinary practices to accelerate the development and application of diagnostic tools. For example, in November 2025, Bionote USA introduced the Vcheck C1 In-Clinic Chemistry Analyzer, an affordable and compact biochemistry testing device tailored for veterinary clinics. This analyzer enables simultaneous testing of up to 24 biochemical parameters from small animal samples within 10 to 12 minutes, providing lab-quality accuracy through a straightforward workflow. Supporting testing across 34 species-including dogs, cats, horses, and cattle-with validated reference ranges, the device offers extensive test panels such as comprehensive chemistry, electrolyte, liver, kidney, and diabetes profiles. Its cost-effectiveness and multi-species compatibility aim to broaden access to fast, on-site biomarker diagnostics in various veterinary environments.

Veterinary Biomarkers Market Segmentation and Scope
The veterinary biomarkers market is categorized into several key segments for a detailed understanding:
1) Product Type: Biomarkers, Kits and Reagents, Biomarker Readers
2) Disease Type: Inflammatory and Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumors, Other Disease Types
3) Animal Type: Companion Animals, Production Animals
4) Application: Disease Diagnostics, Preclinical Research, Other Applications

Further breakdown includes:
- Biomarkers: Diagnostic, Prognostic, Predictive, Pharmacodynamic
- Kits and Reagents: ELISA Kits, PCR Kits, Western Blotting Kits, Rapid Test Kits, Reagents for Biomarker Detection
- Biomarker Readers: Optical Readers, Fluorescence Readers, Luminometers, Real-Time PCR Machines, Microplate Readers

This comprehensive segmentation facilitates a nuanced view of the market, capturing the diversity of products, disease focuses, animal categories, and applications driving growth in veterinary biomarkers.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Market Trend Analysis: The Impact of Recent Advances on the Veterinary Biomarkers Market here

News-ID: 4459596 • Views:

More Releases from The Business Research Company

Key Strategic Factors and Emerging Trends Shaping the Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Market Landscape
Key Strategic Factors and Emerging Trends Shaping the Acute Lymphocytic-Lymphobl …
Understanding the Future of Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics The market for acute lymphocytic-lymphoblastic leukemia (ALL) therapeutics is on track for significant expansion in the years ahead. Driven by advancements in treatment methods and diagnostic technologies, this sector is poised for remarkable growth, reflecting ongoing innovations and increasing investments focused on combating this aggressive form of leukemia. Forecasted Growth and Market Size of Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics The acute lymphocytic-lymphoblastic leukemia therapeutics
Future Perspectives: Key Trends Shaping the Acute Lung Injury Market Until 2030
Future Perspectives: Key Trends Shaping the Acute Lung Injury Market Until 2030
Understanding the future trajectory of the acute lung injury market reveals promising growth driven by medical advancements and evolving treatment methodologies. As the healthcare landscape adapts to rising challenges, the market is set to experience steady expansion through 2030. Let's explore the size, key players, influential trends, and segmentation details shaping this vital sector. Projected Growth and Market Size of the Acute Lung Injury Market The acute lung injury market is
In-Depth Examination of Segments, Industry Developments, and Key Players in the Acute Hospital Care Market
In-Depth Examination of Segments, Industry Developments, and Key Players in the …
The acute hospital care sector is poised for significant expansion as healare systems worldwide adapt to evolving patient needs and technological advancements. With a growing focus on specialized services and improved patient monitoring, this market is set to experience notable growth through 2030. Below, we explore the expected market trajectory, key players, prevailing trends, and the main segments shaping this industry. Forecasted Growth Trajectory of the Acute Hospital Care Market The
Segmentation, Major Trends, and Competitive Overview of the Acute Coronary Syndrome Market
Segmentation, Major Trends, and Competitive Overview of the Acute Coronary Syndr …
The acute coronary syndrome market is positioned for significant expansion over the coming years, driven by advances in medical treatments and evolving healthcare practices. As cardiovascular diseases remain a leading cause of morbidity, innovations and improved healthcare delivery methods are set to play a critical role in shaping this market's trajectory. Here, we examine the market's growth outlook, key players, prevailing trends, and segmentation details that define its current and

All 5 Releases


More Releases for Biomarker

Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Multiplex Biomarker Imaging Market Size By 2025? In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints), Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA. Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference: Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge
Biomarker Testing Market | Agilent Technologies, Roche, ,
The global biomarker testing market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the biomarker testing market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being. CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558 This latest report researches the industry structure,